Navigation Links
AMPLICOR HIV-1 Monitor Test, v1.5

ProductsAMPLICOR HIV-1 Monitor Test, v1.5
Company Roche Diagnostics
Item AMPLICOR HIV-1 Monitor Test, v1.5
Features 
  • High levels of sensitivity for an accurate measurement of viral suppression in patients on anti-retroviral therapy
  • 100% specificity
  • A domain of linearity from 50 to 750,000 copies/mL1
  • Proven performance in major pharmaceutical studies
  • The only FDA-approved test which can measure HIV-1 RNA down to 50 copies/mL
  • Quantification of HIV-1 Group M subtypes A-G
Description The AMPLICOR HIV-1 MONITOR Test, v1.5, an FDA-approved HIV-1 RNA assay, is utilized for HIV-1 viral load testing, has been used in the regulatory approval for HIV-1 therapies, and is now found in eight out of 10 clinical laboratories worldwide.

The AMPLICOR HIV-1 MONITOR Test, v1.5 is an in vitro nucleic acid amplification test for the quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in human plasma. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level and to monitor the effects of anti-retroviral therapy by measuring changes in plasma HIV-1 RNA levels during the course of anti-retroviral treatment.

The Gold Standard in Viral Load Assessment

The AMPLICOR HIV-1 MONITOR Test was the first commercial FDA-approved test to quantify the amount of HIV-1 RNA. This test has been used for FDA approval of most of the currently approved anti-retroviral drugs. With a limited number of treatment regimens available to HIV-1 patients, the accurate monitoring of viral load levels is essential to establish and monitor the effectiveness of therapeutic regimens, assess the potential of drug resistance and identify treatment failure.

Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. OraSure HIV-1 Oral Specimen Collection Device
2. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
3. Reveal Rapid HIV-1 Antibody Test
4. Vironostika HIV-1 Plus O Microelisa System
5. Genetic Systems HIV-1/HIV-2 Peptide EIA
6. ViroSeq HIV-1 Genotyping System
7. Procleix HIV-1/HCV Assay
8. NucliSens HIV-1 QT
9. OraSure HIV-1 Western Blo
10. Genetic Systems HIV-1 Western Blot
11. Cambridge Biotech HIV-1 (Western Blot)
9 mm diameter pigtail curved blunt probes. Stainless steel. Round knurled handle with polished finish. Includes pre-cut polyethylene tubes. Overall length: 5.9 inches.
Yag Laser System SYL is compact and light-weight. It is CE Mark approved according to MDD.
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with thumb catch lock and dull finish.
Farnsworth panel D15 test evaluation has a choice of 4 easy ways to arrange caps with automatic creation 'horse-shoe' diagrams, automatic color deficiency analysis, manual color deficiency analysis,
Medicine Products:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...and that rocks the cradle rules the world! Rightly... child from the moment of birth. //Enabling the ch...not be mere wishful-thinking, and in this age of i...clearly understood, as a foundation for all round ...
... blood test developed by Dr. Edward A. Hirschowitz... early stages in people who are at high risk for d...ing cause of cancer death in United States and aro... diagnosed at a later stage. The incidence of lun...
...rches have found that different genes may be invol...e also noted that other genes may also be involved...pmental disorder in a new study published in the o... Genetics. The study also provides new evidence f...
...orld's first and only cervical cancer vaccine, Gar...s that causes most cervical cancers, may go on sal...he vaccine developed by US pharmaceutical company ...nt effective against the two main strains of the H...
Other Medicine News:Health News:Breast Milk: The Mother of All Milk for Infants 2Health News:Breast Milk: The Mother of All Milk for Infants 3Health News:New Blood Test For Early Detection Of Lung Cancer 2Health News:New Findings on Autism Research 2
(Date:9/5/2008)...monstrates microRNAs Extracted From a Simple Blood...nical Biomarkers for a Wide Range of ... Technology, Rosetta Genomics is Currently Develop...on Cancer, REHOVOT, Israel and JERSEY CITY, New J...ta Genomics, Ltd. (NASDQ: ROSG), a leader in,the d...
(Date:9/4/2008)... first in TaqMan(R) real-time PCR testing for the ...PLEASANTON, Calif., Sept. 4 /- The U....he Roche COBAS(R) TaqMan(R) HBV Test,the first as...d in the U.S.,The test uses Roche,s real-time PCR ...irus DNA in a patient,s blood. Doctors may use vir...
(Date:9/4/2008)... Seeks to Enroll 750 Women at More Than 100 Sites ...e/ -- QuatRx Pharmaceuticals, a,privately-held bio...commercialization of compounds to treat endocrine,...ounced that it has initiated a second,Phase 3 clin... company,s,estrogen-free oral therapy in developme...
(Date:9/4/2008)...timizing Patient Identification for Targeted Thera...ized Treatment HUNTINGTON BEACH, Calif., and AM...dia, a world leader in molecular cancer diagnostic... new diagnostic test that,allows physicians to qua...f,the estrogen receptor (ER), progesterone recepto...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Video 3A Chatto Skincare Unprecedented Breakthrough 23723 1Video 3A Chatto Skincare Unprecedented Breakthrough 23723 2Video 3A Chatto Skincare Unprecedented Breakthrough 23723 3Good news about 244 gas 3F Fewer traffic deaths 23721 1Patients Who Bring Health Information from the Internet Get More Time with Doctor 6488 1Patients Who Bring Health Information from the Internet Get More Time with Doctor 6488 2Patients Who Bring Health Information from the Internet Get More Time with Doctor 6488 3Overstock com Goes Fur Free 23716 1Overstock com Goes Fur Free 23716 2Overstock com Goes Fur Free 23716 3